These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 39037484)

  • 1. Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses.
    Park A; Lee JY
    J Microbiol; 2024 Jul; 62(7):491-509. PubMed ID: 39037484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel System for Simple Rapid Adenoviral Vector Construction to Facilitate CRISPR/Cas9-Mediated Genome Editing.
    Bi Y; Gu L; Wang J; Chang Y; Jin M; Mao Y; Wang H; Ji G
    CRISPR J; 2021 Jun; 4(3):381-391. PubMed ID: 34077671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles.
    Song Z; Tao Y; Liu Y; Li J
    Front Immunol; 2024; 15():1444437. PubMed ID: 39281673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus as an integrating vector.
    Mitani K; Kubo S
    Curr Gene Ther; 2002 May; 2(2):135-44. PubMed ID: 12109211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector.
    Lorincz R; Alvarez AB; Walkey CJ; Mendonça SA; Lu ZH; Martinez AE; Ljungberg C; Heaney JD; Lagor WR; Curiel DT
    Biomed Pharmacother; 2023 Feb; 158():114189. PubMed ID: 36587560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes.
    Ehrke-Schulz E; Schiwon M; Leitner T; Dávid S; Bergmann T; Liu J; Ehrhardt A
    Sci Rep; 2017 Dec; 7(1):17113. PubMed ID: 29215041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Preclinical Developments Using Adenovirus Hybrid Vectors.
    Ehrke-Schulz E; Zhang W; Gao J; Ehrhardt A
    Hum Gene Ther; 2017 Oct; 28(10):833-841. PubMed ID: 28854818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in gene therapy: averting the immune response to adenoviral vectors.
    Ritter T; Lehmann M; Volk HD
    BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9.
    Stephens CJ; Lauron EJ; Kashentseva E; Lu ZH; Yokoyama WM; Curiel DT
    J Control Release; 2019 Mar; 298():128-141. PubMed ID: 30771412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective.
    Jt S; M H; Wam B; Ac B; Sa N
    J Mol Med (Berl); 2022 Jun; 100(6):875-901. PubMed ID: 35606652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.
    Ballmann MZ; Raus S; Engelhart R; Kaján GL; Beqqali A; Hadoke PWF; van der Zalm C; Papp T; John L; Khan S; Boedhoe S; Danskog K; Frängsmyr L; Custers J; Bakker WAM; van der Schaar HM; Arnberg N; Lemckert AAC; Havenga M; Baker AH
    J Virol; 2021 Oct; 95(22):e0038721. PubMed ID: 34469243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of
    Brescia M; Janssen JM; Liu J; Gonçalves MAFV
    Cells; 2020 Apr; 9(4):. PubMed ID: 32252479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy.
    Wang WC; Sayedahmed EE; Mittal SK
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.
    Seiler MP; Cerullo V; Lee B
    Curr Gene Ther; 2007 Oct; 7(5):297-305. PubMed ID: 17979676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-Step Genetic Modification by Embryonic Doral Aorta Injection of Adenoviral CRISPR/Cas9 Vector in Chicken.
    Qin C; Jiang S; Xu K; Zhu J; Wang L; Yang W; Xiao F; Yang K; Huang Q; Meng H
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key to Delivery: The (Epi-)genome Editing Vector Toolbox.
    Just S; Büning H
    Methods Mol Biol; 2018; 1767():147-166. PubMed ID: 29524133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded-capacity adenoviral vectors--the helper-dependent vectors.
    Morsy MA; Caskey CT
    Mol Med Today; 1999 Jan; 5(1):18-24. PubMed ID: 10088128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonintegrating Gene Therapy Vectors.
    Athanasopoulos T; Munye MM; Yáñez-Muñoz RJ
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):753-770. PubMed ID: 28895845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of nonhuman adenoviruses as vaccine vectors.
    Bangari DS; Mittal SK
    Vaccine; 2006 Feb; 24(7):849-62. PubMed ID: 16297508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.